A quantitative view on multivalent nanomedicine targeting.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Selective drug delivery using nanoparticles has been explored for over a century, yet no targeted nanomedicine has achieved clinical approval.
• Designing effective targeted nanoparticles is challenging due to a limited quantitative understanding of cell targeting interactions.
• Current research extensively reports nanoparticles modified with targeting ligands, but rational design remains difficult.

Purpose of the Study:

• To review theoretical models and experimental methods for quantitatively understanding cell targeting interactions.
• To discuss advancements in multivalency theory for the rational design of highly selective nanoparticles.
• To present innovative approaches for obtaining single-cell and single-molecule targeting parameters crucial for nanoparticle design.

Main Methods:

• Review of theoretical advancements in multivalency theory.
• Discussion of experimental methods for quantifying receptor-ligand interactions at the single-cell and single-molecule level.
• Analysis of how these quantitative parameters inform nanoparticle design.

Main Results:

• Multivalency theory provides a framework for designing 'super-selective' nanoparticles.
• Single-cell and single-molecule techniques offer quantitative insights into targeting mechanisms.
• These advancements facilitate a more rational approach to nanoparticle design.

Conclusions:

• Combining advanced multivalency theory with quantitative experimental methods is key to overcoming challenges in targeted nanomedicine design.
• This integrated approach is expected to accelerate the rational design and clinical translation of targeted nanomedicines.
• Understanding and quantifying receptor-ligand interactions at the molecular level is crucial for therapeutic success.